A new procedure involving inhibition of a solid-phase radioimmunoassay was developed for specific determination of the outer-membrane protein and the lipopolysaccharide (LPS) serotypes of meningococci. Antigen was allowed to bind to the wells of a polyvinyl microtiter plate and then reacted with a limiting amount of homologous antibody which had been preincubated with buffer or a standard concentration of inhibiting antigen. The amount of antibody bound per well was quantitated by incubation with excess "25I-labeled goat anti-rabbit immunoglobulin. Typing sera for detecting eight LPS antigens and 18 protein antigens were made in rabbits by use of both the group C and group B bactericidal serotyping strains. Reactions between unabsorbed sera and purified LPS were inhibited in the LPS typing system, whereas reactions between absorbed sera and outer-membrane complex were inhibited in the protein typing system. Outermembrane complex was used as the inhibiting antigen in both cases. Approximately 97% of the 80 group B and C strains tested were LPS typable, and 80% were protein typable. Of 51 group A strains tested, however, only 22% were LPS typable and 14% were protein typable. Several nonreciprocal correlations between the occurrence of particular LPS and protein serotype antigens on the same strain were observed, but in general the protein and LPS serotype antigens appeared to occur independently.
The subcapsular serotype antigens of Neisseria meningitidis have received increasing attention in recent years. These antigens, which are localized in the meningococcal outer membrane (6, 19, 20) , are important in epidemiological studies (2, 8, 14) , in studies on the mechanisms of natural immunity (10) , and in studies directed toward the use of these antigens as vaccines against group B meningococcal disease. Although the serotype antigens have generally been considered to be outer-membrane proteins (6 we have recently demonstrated that meningococci may also be serotyped on the basis of their lipopolysaccharide (LPS) antigens (12) . Several different serological procedures have been described for serotyping meningococci (3-5, 9, 12) and measuring antibodies to the serotype antigens (1, 7, 18, 20) . Bactericidal serotyping (3, 9) and precipitin reactions in agar gels (4, 14) have been the most frequently used methods. These methods, however, do not clearly distinguish between the protein and LPS serotype antigens which are intimately associated in the outer membrane (6, 19, 20) . Although selected serotype deterninants have been correlated with the major outer-membrane protein (5, 6) , anti-LPS antibodies are probably involved in some of the weaker bactericidal serotyping reactions (12) . The existence of two different kinds of outer-membrane antigens that appear to have independent serotype specificities (12) suggests the need for serotyping and assay methods which are capable of clearly distinguishing between the two kinds of antigens.
In the present communication, we describe a solid-phase radioimmunoassay (SPRIA) inhibition method of serotyping that has allowed specific determination of both protein and LPS serotypes with a single antigen extract. The LPS serotyping system employed the same eight typing sera previously described for LPS serotyping by hemagglutination inhibition (12) . The protein serotyping system, however, was made up of antisera to bactericidal serotyping strains characterized by Gold and Wyle (G-W strains; 8, 9) and Frasch and Chapman (F-C Strains; 3-5), as well as several additional strains characterized by the Department of Bacterial Diseases, Walter Reed Army Institute of Research (WR strains). By this system, the protein and LPS serotypes of 142 meningococcal strains, mostly of groups The protein and LPS serotypes of meningococcal strains, as determined by the SPRIA inhibition method, are specified by using a "P" or "L" prefix, respectively. The antigenic profile of a strain is given in parentheses after the strain designation, using the format (serogroup:protein serotype:LPS serotype). For example, the antigenic profile of the group C strain 118V, which has protein antigens 3 and 4 and LPS antigens 2 and 4, is given as 118V(C:P3,4:L2,4).
Bactericidal serotypes are given using the original nomenclature of Gold and Wyle (9) or Frasch and Chapman (3), as appropriate.
Materials and reagents. Polystyrene "U" microtiter plates and polyvinyl, flexible "U" microtiter plates were obtained from Cooke Laboratory Products, Inc., Alexandria, Va.
The phosphate-buffered saline (PBS) was Dulbecco PBS (Grand Island Biological Co., Grand Island, N.Y.). PBS used to dilute antigen for coating the wells of the polyvinyl plates contained 0.02% phenol red as an aid in visualization. The "filter" diluent contained 10% (vol/vol) fetal calf serum, 0.2% sodium azide, and 0.02% phenol red in PBS (pH 7.4). Goat anti-rabbit immunoglobulin (GARG) was obtained from Antibodies Incorporated, Davis, Calif., and labeled with '25I by the lactoperoxidase method as previously described (18) . Subtilisin was obtained from Nutritional Biochemicals Co., Cleveland, Ohio, and Pronase, B grade, free of nucleases, was obtained from Calbiochem, La Jolla, Calif.
Preparation of antigens. Outer-membrane protein and capsular polysaccharide were prepared as previously described (20) . LPS was prepared as previously described (20) or by the phenol-water method of Westphal et al. (17) . Outer-membrane complex (OMC) was prepared from organisms grown either on BYE agar plates (Baltimore Biological Laboratory, Cockeysville, Md.) or in liquid medium as previously described (19) . Normally the cells from four to six plates or from 100 to 200 ml of overnight liquid culture provided enough OMC for protein and LPS serotype determination as well as for analysis of the outermembrane proteins by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, if so desired. OMC was prepared as previously described (20) . Briefly, the cells were suspended in about 25 ml of buffer containing 0.05 M tris(hydroxymethyl)aminomethane-hydrochloride, 0.15 N NaCl, and 0.01 M ethylenediaminetetraacetic acid (pH 7.4). The suspension was heated at 60°C for 30 min, sheared in an Omnimixer (Dupont Instruments/Sorvall, Newtown, Conn.) at full speed for 2 to 3 min, and centrifuged at 20,000 x g for 15 min to remove cells and debris. OMC was then pelleted from the supernatant by centrifugation at 100,000 x g for 2 h. The pellet was washed by suspending in distilled water and repelleting as before. The final pellet was suspended in about 0.5 ml of distilled water, assayed for protein, and diluted with water to 1 mg of protein per ml. The standardized antigen preparations were stored at -200C.
Preparation of antisera. Typing sera were prepared in 2-kg New Zealand white rabbits by giving three intravenous injections of 1 x 107, 1 x 108, and 5 x 108 live meningococci on days 0, 21, and 42, respectively. Rabbits were bled on day 52.
Absorption of antisera with bacterial cells was performed by mixing the serum with one-tenth to onefifth volume of packed cells and placing the mixture on a rotator, first at 37°C for 1 h and then at 4°C for 1 h. The organisms were removed by centrifugation at 10,000 x g for 15 min, alhd the serum was filtered through a 0.45-tum membrane filter (Millipore Corp., Bedford, Mass.). Absorption of sera with LPS was performed by coating sheep erythrocytes with the LPS as previously described (20) and mixing 10 volumes of a 1:10 dilution of heat-inactivated serum with 1 volume of the packed erythrocytes. After 2 h at 37°C, the cells were removed by centrifugation at 2,000 x g for 10 min.
Digestion of OMC with proteolytic enzymes. OMC was diluted to 1 mg of protein per ml with PBS (pH 7.4) or first precipitated from 0.1 M NaCl with 4 volumes of ethanol and then centrifuged, and the pellet was suspended in PBS at 1 mg of protein per ml. Subtilisin or Pronase was added in the amount of 100,ug per mg of OMC protein, and sodium azide was added to 0.1% (wt/vol). Controls received PBS in place of enzyme. The tubes were capped and placed in a 37°C water bath overnight and then were placed in a boiling water bath for 4 min to inactivate the enzymes. Enzyme activity was assayed by using fluorescamine (Roche Diagnostics, Div. Hoffmann-La Roche, Inc., Nutley, N.J.) to measure the increase in primary amino groups with time (16) .
Serotyping by SPRIA inhibition. The SPRIA inhibition was based on the quantitative SPRIA previously described (12) , and the procedure and conditions were the same unless otherwise indicated. The test was performed in "U"-bottom microtiter plates and, in addition to the diluents described above, required four reagents: (i) LPS or OMC homologous to each typing serum was diluted in PBS to 25 or 100 ,ug/ml, respectively. (ii) The rabbit typing sera were diluted in filler to contain a limiting amount of specific antibody. The actual dilution was determined by performing the SPRIA as previously described (18) A scheme of the test is given in Fig. 1 Antigen-coated control wells that received filler in place of an inhibition mixture were used as the background controls. 
RESULTS
Standardization and specificity of the serotyping reactions. Preliminary studies were performed to standardize the procedure and examine the specificity of the serotype reactions. The effect of the inhibiting antigen concentration on the level of inhibition was investigated to determine the concentration required to achieve maximum inhibition. The reaction between antiserum to strain 138I and the homologous OMC was inhibited by various concentrations of OMC from the homologous and several heterologous strains (Fig. 2 VOL. 18, 1977 on October 16, 2017 by guest http://iai.asm.org/ Downloaded from achieved by absorbing the typing sera, as needed, either with the homologous LPS to remove anti-LPS antibodies or with intact organisms of an appropriate heterologous strain to remove antiprotein antibodies with specificities other than those desired. Some of the typing sera were highly specific for a particular protein serotype antigen without absorption. The effectiveness of absorptions and the resulting specificity of the protein serotype reactions were examined by grid inhibition experiments in which the homologous LPS and capsular polysaccharide were included as inhibiting antigens ( Table  2 ). The protein serotype reactions were very specific. Inhibition by the homologous LPS and group polysaccharide was in the range of 0 to 12%, whereas homologous inhibition by the OMC was 88 to 100%. Although OMC from several of the prototype strains inhibited heterologous reactions, heterologous inhibitions above 30% were relatively infrequent. Only inhibition greater than 30% is listed in Table 2 , and inhibition of 50% or greater was considered positive for the purposes of serotyping.
Further evidence that the protein serotype reactions were specific for protein determinants was obtained by examining the effect of digestion with proteolytic enzymes on the ability of the OMC to inhibit the homologous serotype reaction. The inhibitor activity of OMC from eight of the prototype strains before and after digestion with subtilisin is given in Table 3 (Table  4) consisted of antisera to the G-W strains, the F-C strains, and four additional WR strains (3, 8) . Absorptions were made as indicated in Table  4 , and the sera were tested for specificity in grid inhibition experiments as described above. Several antisera made using the F-C strains were found to have specificities essentially identical to antisera made by using one of the G-W strains or WR strains. In these cases, the serum with the cleanest and most specific inhibition pattern was included in the typing system. The identity of the F-C type 2 antigen and the G-W type II Table 6 . Group A strains were again mostly nontypable (78%). All 11 of those that were typable had the L7 antigen(s) plus one or more of the antigens L4, L6, or L8. It thus appears that the LPS antigens of group A strains also differ significantly from those of group B and C strains and are not all identical. All non-group A strains except three were typable with the eight LPS typing sera. The results obtained here agreed with the results obtained by the hemagglutination inhibition method described previously (12) .
The relationship between the occurrences of protein serotype antigens and LPS serotype an- LPS typing sera results in a more complete antigenic description of group B and C meningococcal strains than was previously possible. This approach, however, also raises some questions regarding serotype nomenclature and the relationship between the serotype determined by SPRIA inhibition and that determined by bactericidal tests or other methods. Although the protein typing sera used in the present study were prepared by means of the same strains used by Gold and Wyle (8, 9) and by Frasch and Chapman (3, 4, 5) to prepare their bactericidal typing sera, the specificities expressed by these sera when used in the two different typing procedures may not always be identical. Possible involvement of anti-LPS antibodies in bactericidal serotyping (12), use of typing sera which are probably not monospecific for a single protein determinant, and basic differences in the functions required ofthe type-specific antibodies for expression in the two typing systems could all lead to differences in the results obtained. In those instances where strains had previously VOL. 18, 1977 on October 16, 2017 by guest http://iai.asm.org/ Downloaded from been serotyped by the bactericidal method, we often found agreement between the SPRIA protein type and the bactericidal type (particularly in the case of P2 and P4), but some differences were also observed. For this reason, and the need to distinguish the protein type from the LPS type, we renumbered the different protein types and gave them a "P" prefix rather than attempt to use a combination of the two different bactericidal serotype designations. The LPS serotypes were similarly given an "L" prefix to distinguish them clearly from the protein serotypes. The more common "O" prefix for LPS serotype determinants was not used because it has not been established that these determinants are located on 0-side chains. The antigenic profile of each strain was therefore expressed using the format (serogroup:protein serotype:LPS serotype).
Experiments designed to demonstrate that the antigens involved in the protein serotyping reactions are indeed protein were not conclusive in the case of types P1, P4, and P5. A significant amount of inhibitory activity persisted after treatment of the OMC with proteolytic enzymes. Partial resistance of these membrane antigens to attack by proteolytic enzymes is not surprising, however, since proteins in the gram-negative outer membrane are known to be relatively resistant to attack by proteolytic enzymes (15) . Since a significant decrease in antigenic activity was observed after subtilisin treatment, and partial removal of lipid by ethanol precipitation resulted in more extensive destruction of antigenic activity, it seems probable that the partial resistance of these antigens to proteolytic enzymes was due to their inaccessibility to the enzymes rather than to a nonprotein composition. This conclusion is supported by the fact that no decrease at all in the capacity of the LPS component of the OMC to inhibit the appropriate LPS serotype reaction was observed after treatment with proteolytic enzymes.
Even though the typing sera were generally found to have a high degree of specificity for a particular serotype antigen, it is not likely that the sera are monospecific. Many of these serotype reactions were inhibited at a low level (0 to 30%) by OMC from most other strains tested. This suggests the presence of antibodies to common or cross-reactive determinants. The presence of multiple protein and LPS serotype determinants on many strains also suggests that the serotype specificity defined by some of the serotype reactions may involve more than a single determinant. The present method of serotyping, however, should allow precise definition of each specificity based on quantitative results of inhibition by an appropriate set of test antigens.
When the specificities of the combined set of protein typing sera were compared by grid inhibition experiments, surprisingly little duplication was observed. Only three serotypes (P2, P4, and P9) were detected by antisera to both a G-W or WR strain and an F-C strain. In these cases the serum with the poorest specificity was deleted from the set of typing sera. The resulting 18 typing sera all had different specificities. One advantage in using the combined set of typing sera is evident from the observation that several of the most commonly occurring serotypes (P3, P6, and P10) would not have been detected if typing sera to only the F-C strains or the G-W strains had been used. Even with the combined set of 18 typing sera, only about 78% of the group B and C strains were typable. On the other hand, about half of the serotypes were rarely detected or not detected at all except on the prototype strain. These results suggest the existence of a relatively large number of different protein serotype determinants among group B and C meningococci. Since a higher percentage of strains were typable by a much smaller number of LPS typing sera, LPS serotyping may be more useful than protein serotyping in some epidemiological studies.
Among 51 group A strains tested, 78% were nontypable in the LPS system and 86% were nontypable in the protein system. Only 4 of the 8 LPS types and 1 of 17 protein types were detected among the group A strains. These results indicate that many of the protein and LPS serotype determinants that are common to both group B and group C strains (12, 14) are less common or nonexistent among group A strains. Differences among group A strains, however, were demonstrated by both protein and LPS serotyping. Typing sera prepared with group A strains have recently been used successfully to determine both the protein and LPS serotypes of over 80% of the group A strains tested by SPRIA inhibition (manuscript in preparation).
The significance of several nonreciprocal correlations that were observed between the occurrence of certain protein and LPS serotype antigens (e.g., P2 and 13 or P4 and I4) on the same strains is not yet clear. Epidemiological studies involving a larger number of strains will be required to examine this question and to determine whether particular LPS serotypes have epidemiological significance such as that ascribed to the protein serotype 2 (2, 8, 14) . Overall, the protein and LPS serotype antigens appear to occur independently, and therefore the serotype of each must be separately determined to obtain VOL. 18, 1977 an accurate antigenic profile of meningococcal strains.
The presence of multiple protein and LPS serotype determinants (up to four or five) on a single strain results in a relatively complex antigenic proffie. In light of reports of significant phenotypic variation in outer-membrane components as a result of differences in growth conditions (7, 13) , it will be important to determine to what extent the results of serotyping by SPRIA inhibition are affected by such variations. The protein serotype antigens P3, P6, and P10 often occur together with P2, which has been reported to be located on the major outermembrane protein (6) . The question arises of whether the serotype antigens P3, P6, and P10, which are all susceptible to degradation by proteolytic enzymes and therefore protein in nature, are also located on the major outer-membrane protein.
The SPRIA inhibition method of serotyping has certain significant advantages over existing methods of serotyping. Among these advantages are (i) separate, specific determination of the protein and LPS serotypes using a single antigen preparation, (ii) no requirement for complement, and (iii) quantitative results which are easily subjected to automated data reduction. Modification of the method by substitution of enzymelinked GARG in place of the "2I-labeled GARG would allow the present method to be used in laboratories where gamma-counting equipment is not available. In addition, we have found the SPRIA inhibition procedure to be generally useful for studies of antigenic specificity involving a variety of protein and membrane-associated antigens.
